The Efficiency and Productivity of Indian Pharmaceutical Companies PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Efficiency and Productivity of Indian Pharmaceutical Companies PDF full book. Access full book title The Efficiency and Productivity of Indian Pharmaceutical Companies by Aas Mohammad. Download full books in PDF and EPUB format.
Author: Aas Mohammad
Publisher: Cambridge Scholars Publishing
ISBN: 1527540391
Category : Business & Economics
Languages : en
Pages : 224
Get Book Here
Book Description
This book evaluates the performance of the Indian pharmaceutical industry, which plays an important role in economic development. It highlights the role the government has had in facilitating the growth of the industry from non-existence, before the 1970s, to being one of the largest pharmaceutical industries in the world today. The text employs various useful techniques to provide an understanding of productivity and efficiency, such as data envelopment analysis, stochastic frontier analysis, the Malmquist Productivity Index and the Hicks-Moorsteen Productivity Index. The book will be useful to health administrators, students of public policy, and health economists with an interest in the pharmaceutical sector.
Author: Aas Mohammad
Publisher: Cambridge Scholars Publishing
ISBN: 1527540391
Category : Business & Economics
Languages : en
Pages : 224
Get Book Here
Book Description
This book evaluates the performance of the Indian pharmaceutical industry, which plays an important role in economic development. It highlights the role the government has had in facilitating the growth of the industry from non-existence, before the 1970s, to being one of the largest pharmaceutical industries in the world today. The text employs various useful techniques to provide an understanding of productivity and efficiency, such as data envelopment analysis, stochastic frontier analysis, the Malmquist Productivity Index and the Hicks-Moorsteen Productivity Index. The book will be useful to health administrators, students of public policy, and health economists with an interest in the pharmaceutical sector.
Author: Mainak Mazumdar
Publisher: Springer Science & Business Media
ISBN: 3790828750
Category : Business & Economics
Languages : en
Pages : 215
Get Book Here
Book Description
This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers.
Author: Mainak Mazumdar
Publisher:
ISBN: 9788177911794
Category : Pharmaceutical industry
Languages : en
Pages : 25
Get Book Here
Book Description
Author: Mithun Nandy
Publisher:
ISBN: 9789811669224
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the 'Pharmacy of the World' and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as 'Innovate in India and Serve to the World'. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. Dr. Mithun Nandy has over 16 years of pharmaceutical industry experience and is currently designated as Assistant General Sales Manager in Hegde & Hegde Pharmaceutica LLP, Mumbai, India. He is responsible for the different domestic and international market operations at H&H which are connected to pharmaceutical product promotion and selling. He has presented numerous research papers and posters at different national and international management conferences. He has a good number of empirical research papers published in various reputable peer-reviewed international journals. His professional success story has been featured in IQVIA Sales View. .
Author: H.S Pannu
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
In this paper we have used data envelopment analysis (DEA) and econometric models to analyse the impact of research and development and innovation on relative efficiency and productivity change and firm performance in Indian pharmaceutical industry (IPI) between 1998 and 2007 which covers the post-TRIPS (1995) and post Indian Patent Act Amendment (2005) period. Output oriented BCC DEA model and Malmquist productivity index are used to estimate the relative efficiency and productivity change of Indian pharmaceutical companies over the 10 year period. Using econometric models, we have proposed and tested several hypotheses for the IPI and found a positive impact of innovation represented by R&D investment and patents on productivity (sales), market share, exports and ability to attract contract manufacturing among Indian pharmaceutical companies. We also found that the sales growth is additionally driven by DEA efficiency, size, age which have a positive impact on productivity (sales). Export revenue is additionally driven by sales. Within the limitations of the model discussed, contract manufacturing was additionally driven by innovation, size and sales. The company sales growth was additionally driven by export growth and DEA efficiency. The DEA efficiency having a positive impact on sales and sales growth is a new finding as there appears to be no previous investigation to explore this relationship.
Author: Amalendu Bhunia
Publisher: LAP Lambert Academic Publishing
ISBN: 9783847315131
Category :
Languages : en
Pages : 172
Get Book Here
Book Description
Indian pharmaceutical industry has played a key role in promoting and sustaining development in the vital field of medicines. The goal of financial performance analysis is to determine the efficiency and performance of firm's management, as reflected in the financial reports. The analyst attempts to measure the firm's liquidity, profitability, and other indicators that the business is conducted in a rational and normal way; ensuring enough returns to the shareholders to maintain at least its market value. In this context an attempt has been made an analysis of financial performance of pharmaceutical companies to understand how management of finance plays a crucial role in the growth. The study has been undertaken for the period of twelve years from 1997-98 to 2008-09. In order to analyze financial performance, various accounting ratios and statistical techniques have been used. In this context an attempt has been made an analysis of financial performance of pharmaceutical companies to understand how management of finance plays a crucial role in the growth. The book is a modified version of research project report financially supported by UGC, India.
Author: Chandrima Chakraborty
Publisher: Emerald Publishing Limited
ISBN: 9781837977444
Category : Business & Economics
Languages : en
Pages : 0
Get Book Here
Book Description
Chakraborty and Pal examine the import and export of Indian medicines to understand the place of the industry on a global scale and assess what can be done to become more competitive. The international comparison of this study will appeal and be useful for researchers, industry professionals and policy makers.
Author: Kidambi Padmini
Publisher: LAP Lambert Academic Publishing
ISBN: 9783659398704
Category :
Languages : en
Pages : 456
Get Book Here
Book Description
This book provides a mechanism which improves the efficiency, transparency, accountability of the pharmaceutical companies and builds the confidence of the stakeholders. It also helps in finding the root causes for failure of some pharmaceutical companies and find an appropriate solution to improve their performance. This book may also be useful to researchers, policy makers, research bodies and pharmaceutical companies. This book is sure of good source of information to the readers in general and the students and future researchers at large in particular.
Author: P. Rohitkumar
Publisher: Infotech Publishers
ISBN: 9784158373520
Category : Business & Economics
Languages : en
Pages : 0
Get Book Here
Book Description
GLOBAL PHARMACEUTICAL INDUSTRY The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug firms control more than one-third of this market, many with annual revenue of \ more than US$ 10 billion and profit margins of about 30%. Six are based in the \sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.
Author: G. Shanmugasundaram
Publisher: LAP Lambert Academic Publishing
ISBN: 9783659518171
Category :
Languages : en
Pages : 144
Get Book Here
Book Description
At the time of Independence, the pharmaceutical industry in India was dominated by MNC's with almost no role for the Indian companies. Indian companies however, started to grow since 1970 with the implementation of IPA 1970, DPCO, FERA 1973 and import tariff and came to dominating the industry in 1990. In 1991, the implementation of globalisation policy brought about reversal of the situation for the Indian companies and favorable to the MNC's. Nevertheless, the Indian pharmaceutical companies showed significant improvement in formulation production, formulation consumption and total consumption, decrease in the formulation imports, decrease in the bulk drugs production, increase in bulk drugs imports and also increase in the foreign exchange earnings. The performance of the Indian pharmaceutical industry as measured through various parameters, has shown that there had been increase in the production, consumption, exports and foreign exchange earnings and decreased in the imports as a result of globalisation. The exports and imports of pharmaceuticals have shown that India is moving towards "only exporting country" with reference to pharmaceuticals.
